Research output per year
Research output per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Robbert Hoogeboom is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A 3-week pause versus continued Bruton tyrosine kinase inhibitor use during COVID-19 vaccination in individuals with chronic lymphocytic leukaemia (IMPROVE trial): a randomised, open-label, superiority trial
Cook, J. A., Patten, P. E. M., Peckham, N., Moss, P., Phillips, N., Abhishek, A., Roberts, T., Hodges, M., Talbot, G., Barber, V., Francis, A., Shields, A. M., Duley, L., Hoogeboom, R., Willett, B. J., Scott, S., Parry-Jones, N., Eyre, T. A., Plested, G. & Vandici, G. & 8 others, , Apr 2025, In: The Lancet Haematology. 12, 4, p. e294-e303Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus) -
Proliferating CLL cells express high levels of CXCR4 and CD5
Friedman, D., Mehtani, D., Vidler, J. B., Patten, P. & Hoogeboom, R., 31 Oct 2024, (Accepted/In press) In: HemaSphere.Research output: Contribution to journal › Article
Open AccessFile7 Downloads (Pure) -
Myosin IIa promotes antibody responses by regulating B cell activation, acquisition of antigen, and proliferation
Hoogeboom, R., Natkanski, E., Nowosad, C., Malinova, D., Menon, R., Casal, A. & Tolar, P., 22 May 2018, In: Cell Reports. 23, 8, p. 2342-2353Research output: Contribution to journal › Article › peer-review
Open AccessFile21 Citations (Scopus)216 Downloads (Pure) -
Myosin II Synergizes with F-Actin to Promote DNGR-1-Dependent Cross-Presentation of Dead Cell-Associated Antigens
Schulz, O., Hanč, P., Böttcher, J. P., Hoogeboom, R., Diebold, S. S., Tolar, P. & Reis e Sousa, C., 10 Jul 2018, In: Cell Reports. 24, 2, p. 419-428 10 p.Research output: Contribution to journal › Article › peer-review
Open Access35 Citations (Scopus) -
B-Lymphoblastic Lymphomas Evolving from Follicular Lymphomas Co-Express Surrogate Light Chains and Mutated Gamma Heavy Chains
Slot, L. M., Hoogeboom, R., Smit, L. A., Wormhoudt, T. A. M., Biemond, B. J., Oud, M. E. C. M., Schilder-Tol, E. J. M., Mulder, A. B., Jongejan, A., van Kampen, A. H. C., Kluin, P. M., Guikema, J. E. J., Bende, R. J. & van Noesel, C. J. M., Dec 2016, In: American Journal of Pathology. 186, 12, p. 3273-3284Research output: Contribution to journal › Article › peer-review
Open AccessFile25 Citations (Scopus)118 Downloads (Pure)
Projects
- 7 Finished
-
Identifying subfractions of CLL cells that are primed for activation in the tissue microenvironment
Friedman, D. (Primary Investigator) & Hoogeboom, R. (Co-Investigator)
1/01/2023 → 25/02/2024
Project: Research
-
IMPROVE
Patten, P. (Primary Investigator) & Hoogeboom, R. (Co-Investigator)
NIHR National Institute For Health & Care Research
1/08/2022 → 31/01/2024
Project: Research
-
Identifying the most dangerous cells in B cell chronic lymphocytic leukaemia
Hoogeboom, R. (Primary Investigator), Karimi, M. M. (Co-Investigator) & Patten, P. (Co-Investigator)
1/05/2022 → 30/04/2025
Project: Research
-
B-cell receptor configuration in normal and malignant B-cells: implications for targeted therapy?
Hoogeboom, R. (Primary Investigator), Devereux, S. (Co-Investigator) & Patten, P. (Co-Investigator)
1/03/2020 → 18/09/2022
Project: Research
-
Antigen-dependent BCR signalling in the expansion of Chronic Lymphocytic Leukaemia
Hoogeboom, R. (Primary Investigator)
1/01/2020 → 31/01/2022
Project: Research